600812.SS
North China Pharmaceutical Company Ltd. [600812.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600812.SS Stock Summary
Top 600812.SS Correlated Resources
600812.SS
Top 10 Correlated ETFs
600812.SS
Top 10 Correlated Stocks
600812.SS
In the News
600812.SS Financial details
Company Rating
-
Market Cap
8.05B
Income
4.89M
Revenue
10.09B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
10.16K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
-12.95
Forward P/E
-
PEG
1.29
P/S
0.87
P/B
1.71
P/C
-
P/FCF
-10.75
Quick Ratio
0.57
Current Ratio
0.82
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-100.7%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-52.01%
Revenue last 5Y
-1.64%
Revenue Q/Q
-22.66%
EPS Q/Q
-1787.5%
-
-
-
-
SMA20
-5.22%
SMA50
-5.67%
SMA100
7.35%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-13%
ROC
-0.06%
Gross Margin
32%
Oper. Margin
-5%
Profit Margin
-7%
Payout
-70%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.83-6.66
52W High
+0.83%
52W Low
+101.67%
RSI
50.36
Rel Volume
1
Avg Volume
13.49M
Volume
13.47M
Perf Week
0.67%
Perf Month
-5.17%
Perf Quarter
7.08%
Perf Half Y
2.89%
-
-
-
-
Beta
0.835
-
-
Volatility
0.07%, 0.23%
Prev Close
-0.33%
Price
6.05
Change
3.6%
Company Profile
- Volume Average 13.49M
- Market Capitalization 8.05B
- Employee 10.16K
- CEO Mr. Xin Yan Liu
- Headquarters Shijiazhuang,CN
- IPO Date 1994-01-14
-
Website
https://www.ncpc.cn 
North China Pharmaceutical Company Ltd. operates as a chemical pharmaceutical company in China. It primarily offers anti-infective drugs, comprising APIs, and intermediates and their preparations; biotechnology drugs; cardiovascular and immunomodulators; vitamins health consumer products; and bio-agricultural and veterinary drugs. North China Pharmaceutical Company Ltd. was founded in 1953 and is based in Shijiazhuang, China.
